ASPEN PHARMACARE HOLDINGS LIMITED - Trading Statement

Trading Statement

Aspen Pharmacare Holdings Limited
(Incorporated in the Republic of South Africa)
(Registration number 1985/002935/06)
Share code: APN & ISIN: ZAE000066692
("Aspen")



Trading statement

Aspen shareholders are hereby advised that, diluted normalised headline earnings per
share (“DNHEPS”) from continuing operations, headline earnings per share and
earnings per share for the 6 months ended 31 December 2012, are expected to exceed
those reported in the comparative period, ended 31 December 2011, within the following
ranges:

                Measure                             Range                    Notes
DNHEPS from continuing operations                 21% to 25%                   1
Headline earnings per share                       15% to 19%                   2
Earnings per share                                 5% to 9%                    3


Notes:

1. DNHEPS from continuing operations comprises diluted headline earnings per share
   adjusted for transaction costs, restructure costs and foreign exchange movements on
   transaction accounting. DNHEPS is the primary measure used by management to
   assess Aspen’s underlying operating performance.

2. The growth in headline earnings per share has been diluted by the effect of an
   increase in the weighted average number of ordinary shares in issue as a
   consequence of the conversion of 17.6 million preference shares into an equivalent
   number of ordinary shares on 28 June 2012.

3. The growth in earnings per share has been diluted as a result of capital profits on the
   disposal of discontinued businesses and products in the prior year and the effect of
   an increase in the weighted average number of ordinary shares in issue as a
   consequence of the conversion of 17.6 million preference shares into an equivalent
   number of ordinary shares on 28 June 2012.


The financial results on which this trading announcement is based have not been
reviewed or reported on by Aspen`s external auditors.

Aspen`s interim results for the 6 months ended 31 December 2012 are scheduled to be
published on SENS on 7 March 2013.

Durban
21 February 2013

Sponsor: Investec Bank Limited

Date: 21/02/2013 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.